Wise Road considers sale of semiconductor company UTAC for around $3bn – report

China-based private equity firm Wise Road Capital is contemplating the sale of UTAC Holdings, a semiconductor assembly and testing company, reported Bloomberg, citing sources.

Wise Road has engaged an undisclosed adviser to explore a potential sale of UTAC, which could value the company at approximately $3bn (S$3.93bn), the sources told the publication.

The deliberations regarding the sale of the Singapore-based company are still in the preliminary stages, and it is possible that Wise Road may choose not to proceed, the report said.

Neither Wise Road nor UTAC have offered any comments on the potential sale so far.

UTAC was acquired by Wise Road in 2020 from a group of shareholders including Affinity Equity Partners and TPG.

UTAC Holdings is engaged in providing a suite of semiconductor assembly and testing services, catering to product categories such as analogue, mixed-signal and logic, and memory.

The company has production facilities across Singapore, Thailand, China and Indonesia.

UTAC’s global sales network targets the US, Europe, China and Taiwan, Japan and the rest of Asia, with sales offices established in each of these five regions.

The company’s clientele primarily consists of fabless companies, integrated device manufacturers and wafer foundries.

Wise Road’s investment focus encompasses sectors such as semiconductors, automotive electronics, robotics, the Internet of Things and sustainability.

Its investors range from technology companies to financial institutions and family offices.

“Wise Road considers sale of semiconductor company UTAC for around $3bn – report” was originally created and published by Verdict, a GlobalData owned brand.

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.